Access Part 1 of this interview in which Scarboro explains why real-world usability belongs at product definition. Access ...

The FDA approves remibrutinib for symptomatic dermographism, the first such therapy, extending an oral BTK inhibitor label ...

Thermo Fisher Scientific announced it is showcasing new and expanded services at CPHI Milan, which is happening from October 6-8, 2026. The company will be presenting new drug dev ...

The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a ...

Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma ...

"What matters is that someone owns the entire pathway for that product from identifying the unmet need through development, ...

On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.

Companies showcasing equipment and services at the event include Shilpa Biologicals (Booth 12J33), which is announcing the ...

In US regulatory news, the FDA opened applications for its Expedited IND Pilot on September 15. 1 The program pairs drug ...

Manufacturers are encouraged to treat resiliency policy as an actionable trend and proactively shape solutions rather than ...

Nitrosamine have been a problem in pharmaceutical manufacturing since approximately 2018, after the carcinogenicimpurities were found in statin drugs. Since then, regulators and pharmaceutical ...

The deal also gives Novartis exclusive options to license additional next-generation programs built on Abogen's proprietary ...